{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:07:35Z","timestamp":1787933255659,"version":"build-2784847793"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.4103\/1673-5374.375328","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T08:10:01Z","timestamp":1685002201000},"page":"212-219","source":"Crossref","is-referenced-by-count":7,"title":["Increasing \u03b2-hexosaminidase A activity using genetically modified mesenchymal stem cells"],"prefix":"10.4103","volume":"19","author":[{"given":"Alisa A.","family":"Shaimardanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria S.","family":"Chulpanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriya V.","family":"Solovyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaza S.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysilu I.","family":"Mullagulova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina A.","family":"Titova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana O.","family":"Mukhamedshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Timofeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Aimaletdinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam R.","family":"Nigmetzyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert A.","family":"Rizvanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-34-20230626","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1534\/genetics.113.160846","article-title":"Simultaneous expression of multiple proteins under a single promoter in Caenorhabditis elegans via a versatile 2A-based toolkit","volume":"196","author":"Ahier","year":"(2014)","journal-title":"Genetics"},{"key":"R2-34-20230626","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.nbd.2005.04.017","article-title":"Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts","volume":"20","author":"Arfi","year":"(2005)","journal-title":"Neurobiol Dis"},{"key":"R3-34-20230626","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11064-012-0718-0","article-title":"Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice","volume":"37","author":"Arthur","year":"(2012)","journal-title":"Neurochem Res"},{"key":"R4-34-20230626","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.hoc.2017.06.007","article-title":"Nonintegrating gene therapy vectors","volume":"31","author":"Athanasopoulos","year":"(2017)","journal-title":"Hematol Oncol Clin North Am"},{"key":"R5-34-20230626","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/hgtb.2011.034","article-title":"Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences","volume":"23","author":"Aurnhammer","year":"(2012)","journal-title":"Hum Gene Ther Methods"},{"key":"R6-34-20230626","doi-asserted-by":"crossref","first-page":"e1233","DOI":"10.1542\/peds.2011-0078","article-title":"Natural history of infantile G(M2) gangliosidosis","volume":"128","author":"Bley","year":"(2011)","journal-title":"Pediatrics"},{"key":"R7-34-20230626","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/jnc.15136","article-title":"Substrate reduction therapy using Genz-667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease","volume":"156","author":"Blumenreich","year":"(2021)","journal-title":"J Neurochem"},{"key":"R8-34-20230626","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/mtm.2016.35","article-title":"Rapid, scalable, and low-cost purification of recombinant adeno-associated virus produced by baculovirus expression vector system","volume":"3","author":"Buclez","year":"(2016)","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R9-34-20230626","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1566523218666180404162622","article-title":"Genetics and therapies for GM2 gangliosidosis","volume":"18","author":"Cachon-Gonzalez","year":"(2018)","journal-title":"Curr Gene Ther"},{"key":"R10-34-20230626","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/bioengineering7020059","article-title":"Human mesenchymal stem cells overexpressing interleukin 2 can suppress proliferation of neuroblastoma cells in co-culture and activate mononuclear cells in vitro","volume":"7","author":"Chulpanova","year":"(2020)","journal-title":"Bioengineering (Basel"},{"key":"R11-34-20230626","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/ijms17071065","article-title":"Less is more:substrate reduction therapy for lysosomal storage disorders","volume":"17","author":"Coutinho","year":"(2016)","journal-title":"Int J Mol Sci"},{"key":"R12-34-20230626","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/mt.2015.106","article-title":"Arylsulfatase A overexpressing human ipsc-derived neural cells reduce CNS sulfatide storage in a mouse model of metachromatic leukodystrophy","volume":"23","author":"Doerr","year":"(2015)","journal-title":"Mol Ther"},{"key":"R13-34-20230626","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13023-022-02378-7","article-title":"Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease","volume":"17","author":"Donald","year":"(2022)","journal-title":"Orphanet J Rare Dis"},{"key":"R14-34-20230626","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/cells8070727","article-title":"Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis","volume":"8","author":"Doyle","year":"(2019)","journal-title":"Cells"},{"key":"R15-34-20230626","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy:long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"(2022)","journal-title":"Lancet"},{"key":"R16-34-20230626","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","article-title":"Hematopoietic stem- and progenitor-cell gene therapy for Hurler syndrome","volume":"385","author":"Gentner","year":"(2021)","journal-title":"N Engl J Med"},{"key":"R17-34-20230626","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/hmg\/7.5.831","article-title":"Retrovirus-mediated enzymatic correction of Tay-Sachs defect in transduced and non-transduced cells","volume":"7","author":"Guidotti","year":"(1998)","journal-title":"Hum Mol Genet"},{"key":"R18-34-20230626","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/mt.2012.214","article-title":"Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis","volume":"21","author":"Harrison","year":"(2013)","journal-title":"Mol Ther"},{"key":"R19-34-20230626","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2014.10.049","article-title":"Neurotrophic factors for spinal cord repair:Which, where, how and when to apply, and for what period of time?","volume":"1619","author":"Harvey","year":"(2015)","journal-title":"Brain Res"},{"key":"R20-34-20230626","doi-asserted-by":"crossref","first-page":"e63247","DOI":"10.1371\/journal.pone.0063247","article-title":"Comparison of internal ribosome entry site (IRES) and Furin-2A (F2A) for monoclonal antibody expression level and quality in CHO cells","volume":"8","author":"Ho","year":"(2013)","journal-title":"PLoS One"},{"key":"R21-34-20230626","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/brain\/awx311","article-title":"Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy","volume":"141","author":"Holley","year":"(2018)","journal-title":"Brain"},{"key":"R22-34-20230626","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/hum.2016.013","article-title":"Novel vector design and hexosaminidase variant enabling self-complementary adeno-associated virus for the treatment of tay-sachs disease","volume":"27","author":"Karumuthil-Melethil","year":"(2016)","journal-title":"Hum Gene Ther"},{"key":"R24-34-20230626","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.ymthe.2021.07.010","article-title":"A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system","volume":"29","author":"Kondratov","year":"(2021)","journal-title":"Mol Ther"},{"key":"R25-34-20230626","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/5584_2021_639","article-title":"Stem cell applications in lysosomal storage disorders:progress and ongoing challenges","volume":"1347","author":"Kose","year":"(2021)","journal-title":"Adv Exp Med Biol"},{"key":"R26-34-20230626","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.3390\/ijms22136751","article-title":"Investigating immune responses to the scAAV9-HEXM gene therapy treatment in Tay-Sachs disease and Sandhoff disease mouse models","volume":"22","author":"Kot","year":"(2021)","journal-title":"Int J Mol Sci"},{"key":"R27-34-20230626","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nm0496-424","article-title":"Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells","volume":"2","author":"Lacorazza","year":"(1996)","journal-title":"Nat Med"},{"key":"R28-34-20230626","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.3390\/ijms21176213","article-title":"GM2 gangliosidoses:clinical features, pathophysiological aspects, and current therapies","volume":"21","author":"Leal","year":"(2020)","journal-title":"Int J Mol Sci"},{"key":"R29-34-20230626","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.3928\/19382359-20180424-01","article-title":"Enzyme replacement therapy:a review and its role in treating lysosomal storage diseases","volume":"47","author":"Li","year":"(2018)","journal-title":"Pediatr Ann"},{"key":"R30-34-20230626","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/mt.2016.104","article-title":"Neural stem cells engineered to express three therapeutic factors mediate recovery from chronic stage CNS autoimmunity","volume":"24","author":"Li","year":"(2016)","journal-title":"Mol Ther"},{"key":"R32-34-20230626","first-page":"91","article-title":"Hematopoietic stem cell transplant for lysosomal storage diseases","volume":"11","author":"Lund","year":"(2013)","journal-title":"Pediatr Endocrinol Rev"},{"key":"R33-34-20230626","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/0929867328666210526144654","article-title":"Enzyme replacement therapy for genetic disorders associated with enzyme deficiency","volume":"29","author":"Marchetti","year":"(2022)","journal-title":"Curr Med Chem"},{"key":"R34-34-20230626","doi-asserted-by":"crossref","first-page":"20177","DOI":"10.1074\/jbc.M106164200","article-title":"Absence of metabolic cross-correction in Tay-Sachs cells:implications for gene therapy","volume":"277","author":"Martino","year":"(2002)","journal-title":"J Biol Chem"},{"key":"R35-34-20230626","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"(2017)","journal-title":"BioDrugs"},{"key":"R36-34-20230626","doi-asserted-by":"crossref","first-page":"104667","DOI":"10.1016\/j.nbd.2019.104667","article-title":"Novel bicistronic lentiviral vectors correct beta-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny:implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis","volume":"134","author":"Ornaghi","year":"(2020)","journal-title":"Neurobiol Dis"},{"key":"R37-34-20230626","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41434-019-0120-5","article-title":"A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases","volume":"27","author":"Ou","year":"(2020)","journal-title":"Gene Ther"},{"key":"R38-34-20230626","doi-asserted-by":"crossref","first-page":"114234","DOI":"10.1016\/j.addr.2022.114234","article-title":"Blood-brain barrier delivery for lysosomal storage disorders with IgG-lysosomal enzyme fusion proteins","volume":"184","author":"Pardridge","year":"(2022)","journal-title":"Adv Drug Deliv Rev"},{"key":"R39-34-20230626","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","article-title":"Mesenchymal stem cell perspective:cell biology to clinical progress","volume":"4","author":"Pittenger","year":"(2019)","journal-title":"NPJ Regen Med"},{"key":"R40-34-20230626","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"(2018)","journal-title":"Nat Rev Dis Primers"},{"key":"R41-34-20230626","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles:exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"(2013)","journal-title":"J Cell Biol"},{"key":"R42-34-20230626","doi-asserted-by":"crossref","first-page":"1759091415569908","DOI":"10.1177\/1759091415569908","article-title":"AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system","volume":"7","author":"Rockwell","year":"(2015)","journal-title":"ASN Neuro"},{"key":"R43-34-20230626","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","article-title":"Human immune responses to adeno-associated virus (AAV) vectors","volume":"11","author":"Ronzitti","year":"(2020)","journal-title":"Front Immunol"},{"key":"R44-34-20230626","doi-asserted-by":"crossref","first-page":"885639","DOI":"10.3389\/fonc.2022.885639","article-title":"New indications for hematopoietic stem cell gene therapy in lysosomal storage disorders","volume":"12","author":"Rossini","year":"(2022)","journal-title":"Front Oncol"},{"key":"R45-34-20230626","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","article-title":"Gangliosides and gangliosidoses:principles of molecular and metabolic pathogenesis","volume":"33","author":"Sandhoff","year":"(2013)","journal-title":"J Neurosci"},{"key":"R46-34-20230626","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0009-3084(99)00086-9","article-title":"Hematopoietic stem cell gene therapy for Niemann-Pick disease and other lysosomal storage diseases","volume":"102","author":"Schuchman","year":"(1999)","journal-title":"Chem Phys Lipids"},{"key":"R47-34-20230626","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy:an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"(2016)","journal-title":"Lancet"},{"key":"R48-34-20230626","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/1673-5374.314310","article-title":"Functionality of a bicistronic construction containing HEXA and HEXB genes encoding beta-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses","volume":"17","author":"Shaimardanova","year":"(2022)","journal-title":"Neural Regen Res"},{"key":"R49-34-20230626","doi-asserted-by":"crossref","first-page":"576221","DOI":"10.3389\/fmed.2020.576221","article-title":"Metachromatic leukodystrophy:diagnosis, modeling, and treatment approaches","volume":"7","author":"Shaimardanova","year":"(2020)","journal-title":"Front Med (Lausanne"},{"key":"R50-34-20230626","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/pharmaceutics11110580","article-title":"Production and application of multicistronic constructs for various human disease therapies","volume":"11","author":"Shaimardanova","year":"(2019)","journal-title":"Pharmaceutics"},{"key":"R51-34-20230626","first-page":"1007","article-title":"Serum cytokine profile, beta-hexosaminidase A enzymatic activity and GM2 ganglioside levels in the plasma of a Tay-Sachs disease patient after cord blood cell transplantation and curcumin administration:a case report","volume":"11","author":"Shaimardanova","year":"(2021)","journal-title":"Life (Basel"},{"key":"R52-34-20230626","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3389\/fphys.2018.01663","article-title":"New approaches to Tay-Sachs disease therapy","volume":"9","author":"Solovyeva","year":"(2018)","journal-title":"Front Physiol"},{"key":"R53-34-20230626","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12010-019-03128-5","article-title":"In Vitro Angiogenic Properties of Plasmid DNA Encoding SDF-1alpha and VEGF165 Genes","volume":"190","author":"Solovyeva","year":"(2020)","journal-title":"Appl Biochem Biotechnol"},{"key":"R54-34-20230626","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00467-017-3816-z","article-title":"Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases","volume":"34","author":"Stahl","year":"(2019)","journal-title":"Pediatr Nephrol"},{"key":"R55-34-20230626","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41598-022-04892-x","article-title":"Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression","volume":"12","author":"Starikova","year":"(2022)","journal-title":"Sci Rep"},{"key":"R56-34-20230626","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"(2021)","journal-title":"Nat Rev Drug Discov"},{"key":"R57-34-20230626","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1038\/mtm.2015.57","article-title":"Construction of a hybrid beta-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo","volume":"3","author":"Tropak","year":"(2016)","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R58-34-20230626","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1471-4159.2005.03317.x","article-title":"Metabolic correction in microglia derived from Sandhoff disease model mice","volume":"94","author":"Tsuji","year":"(2005)","journal-title":"J Neurochem"},{"key":"R59-34-20230626","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s12015-020-10000-1","article-title":"Genetically modified mesenchymal stromal\/stem cells:application in critical illness","volume":"16","author":"Varkouhi","year":"(2020)","journal-title":"Stem Cell Rev Rep"},{"key":"R60-34-20230626","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrm.2017.108","article-title":"Mechanical forces direct stem cell behaviour in development and regeneration","volume":"18","author":"Vining","year":"(2017)","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R61-34-20230626","first-page":"102","article-title":"Mucopolysaccharidosis type I","volume":"1","author":"Wraith","year":"(2014)","journal-title":"Pediatr Endocrinol Rev 12 Suppl"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.375328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:10:07Z","timestamp":1787760607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.375328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.375328","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}